Enhanced suppression of cortisol after dexamethasone in borderline personality disorder. A pilot study;Hipersupresión de cortisol con dexametasona en el trastorno límite de la personalidad. Un estudio piloto

Actas Espanolas de Psiquiatria

Volumn 31, Issue 3, 2003, Pages 138-141

  Carrasco, José Luis ^a   Diaz Marsa M ^b   Ignacio Pastrana, J ^b   Molina, R ^b   Brotons, L ^b   Horcajadas, C ^b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Borderline personality disorder; Childhood abuse; Cortisol; Dexamethasone; Hypothalamic pituitary adrenal axis; Trauma

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ADULT; ARTICLE; BORDERLINE STATE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR DEPRESSION; MEASUREMENT; PERSONALITY DISORDER; PILOT STUDY; PSYCHOSIS;

ADMINISTRATION, ORAL; BORDERLINE PERSONALITY DISORDER; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PILOT PROJECTS; PITUITARY-ADRENAL SYSTEM;

EID: 0041565434     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. a ed. Barcelona: Masson; 1995.
2. Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, et al. Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive agressive behavior. Arch Gen Psychiatry 1990;46:587-99.
3. Soloff PH, Cornelius J, Foglia J, George A, Perel JM. Platelet MAO in borderline personality disorder. Biol Psychiatry 1991;29(5):499-502.
4. Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality disordered subjects. Arch Gen Psychiatry 1997;54:1081-8.
5. Coccaro EE Lawrence T, Trestman RL. Growth hormone response to intravenous clonidine challenge correlate with behavioral irritability in psychiatric patients and in healthy volunteers. Psychiatric Res 1991;39:129-39.
6. Steinberg BJ, Trestman RL, Siever LJ. The cholineergic and noradreniergic transmitter systems and affective instability in borderline personality disorder. En: Silk KR, editor. Biological and neurobehavioral studies of borderline personality disorder. Washington: American Psychiatric Press, 1994; p. 41-62.
7. Grossman R, Yehuda R, Siever LJ. The dexamethasone suppression test and glucocorticoid receptors in borderline personality disorder. Ann N Y Acad Sci 1997;21(821): 459-64.
8. Yehuda R, Southwick SM, Kristal JH, Bremner D, Charney DS, Mason JW. Enhanced suppresión of cortisol following dexamethasone administration in postraumatic stress disorder. Am J Psychiatry 1993;150: 83-6.
9. Spitzer RL, Williams JB, Gibbon M, First MB. The sructured clini al interview for DSM-III R (SCID): history, rationale and description. Arch Gen Psychiatry 1992;49:624-9.
10. Zanarini MC, Gunderson JG, Marino MF. Childhood experiences of borderline patients. Compr Psychiatry 1989; 30:18-25.
11. Paris J, Weig-Frank H. A critical review of the role of childhood sexual abuse in the etiology of borderline personality disorder. Can J Psychiatry 1992;37:125-8.
12. New AS, Yehuda R, Steinberg B. Self-reported abuse and biological measures in personality disorders, (abstract). Biol Psychiatry 1996;39:535.
13. Herman J. Trauma and recovery. New York: Basic Books, 1992.
14. Rinne T, De Kloet ER, Wouters L, Goekoop JG, DeRijk RH, van den Brink W. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin releasing hormone challenge in female borderline personality diosrder subjects with a history of sustained childhood abuse. Biol Psychiatry 2002;52(11): 1102-12.
15. Siever LJ, New AS, Kirrane MD, Novotny SH, Koenisberg H, Grossman R. New biological strategies for personality disorders. En: Silk K, editor. Biology of personality disorders, 1998; p. 27-62.
16. Novotny S, Lowry MT. Short-term and long-term effects of p-chloroamphetamine on hippocampal serotonin and corticosteroid receptor levels. Brain Res 1995;684:19-25.